| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Jun―20 |
Impact of COVID-19 on the management of hypertension: a perspective on disease severity, service use patterns and expenditures from Ghana’s health insurance claims data |
Ama Pokuaa Fenny, Evans Otieku, Samuel Owusu Achiaw, Bernard Okoe Boye, Francis Asenso-Boadi, Vivian Addo-Cobbiah, Mariam Musah |
| 2 |
[GO] |
2022―Jul―18 |
The influence of the pandemic on fear of contagion, blood pressure management and adherence to medication in hypertensive older adults in Turkey |
Ayşegül Özcan, İlknur Aydın Avcı |
| 3 |
[GO] |
2022―Jul―05 |
The effects of antihypertensive medications on severity and outcomes of hypertensive patients with COVID-19 |
Samira Nakhaie, Rostam Yazdani, Mohammadreza Shakibi, Soheila Torabian, Sara Pezeshki, Maliheh Sadat Bazrafshani, et al. (+2) Maryam Azimi, Faranak Salajegheh |
| 4 |
[GO] |
2021―Nov―12 |
Bioengineered angiotensin-converting-enzyme-2: a potential therapeutic option against SARS-CoV-2 infection |
Biplab K. Maiti |
| 5 |
[GO] |
2021―Sep―10 |
Resistant hypertension and COVID-19: tip of the iceberg? |
Marijana Tadic, Cesare Cuspidi |
| 6 |
[GO] |
2021―Aug―05 |
The effect of resistant hypertension on in-hospital mortality in patients hospitalized with COVID-19 |
Ferhat Işık, Murat Çap, Abdurrahman Akyüz, Önder Bilge, Burhan Aslan, Ümit İnci, et al. (+6) İlyas Kaya, Ercan Taştan, Metin Okşul, Neşe Kanbal Çap, Ali Karagöz, Erkan Baysal |
| 7 |
[GO] |
2021―Jan―22 |
COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society |
Christopher E. Clark, Sinead T. J. McDonagh, Richard J. McManus, Una Martin |
| 8 |
[GO] |
2020―Dez―14 |
A historical perspective on ACE2 in the COVID-19 era |
Vivek Bhalla, Catherine A. Blish, Andrew M. South |
| 9 |
[GO] |
2020―Dez―10 |
A small contribution to mitigate the collision of transmissible and chronic diseases, exemplified by the management of hypertension during the COVID-19 pandemic |
Gloria Valdés, Carlos Zúñiga |
| 10 |
[GO] |
2020―Nov―09 |
The outcomes of the postulated interaction between SARS-CoV-2 and the renin-angiotensin system on the clinician’s attitudes toward hypertension treatment |
Cenk Sarı, Ersin Çağrı Şimşek, Öner Özdoğan |
| 11 |
[GO] |
2020―Sep―17 |
Promising effects of exercise on the cardiovascular, metabolic and immune system during COVID-19 period |
Isley Jesus, Valentin Vanhee, Therese B. Deramaudt, Marcel Bonay |
| 12 |
[GO] |
2020―Aug―24 |
Association between renin-angiotensin-aldosterone system inhibitor treatment, neutrophil-lymphocyte ratio, D-Dimer and clinical severity of COVID-19 in hospitalized patients: a multicenter, observational study |
Selcuk Gormez, Erkan Ekicibasi, Aleks Degirmencioglu, Ashok Paudel, Refik Erdim, Hilal Kurtoglu Gumusel, et al. (+6) Elif Eroglu, Ibrahim Halil Tanboga, Sinan Dagdelen, Nevin Sariguzel, Ceyda Erel Kirisoglu, Burak Pamukcu |
| 13 |
[GO] |
2020―Aug―13 |
Vitamin D deficiency in African Americans is associated with a high risk of severe disease and mortality by SARS-CoV-2 |
Virna Margarita Martín Giménez, Felipe Inserra, León Ferder, Joxel García, Walter Manucha |
| 14 |
[GO] |
2020―Jul―27 |
Covid-19 and the cardiovascular system: a comprehensive review |
Rafael Bellotti Azevedo, Bruna Gopp Botelho, João Victor Gonçalves de Hollanda, Leonardo Villa Leão Ferreira, Letícia Zarur Junqueira de Andrade, Stephanie Si Min Lilienwald Oei, et al. (+2) Tomás de Souza Mello, Elizabeth Silaid Muxfeldt |
| 15 |
[GO] |
2020―Mai―14 |
Managing hypertension during the COVID-19 pandemic |
Sunil K. Nadar, Muzahir H. Tayebjee, Michael Stowasser, James Brian Byrd |
